Published: November 30, 2017

Introduction {#sec1}
============

A major block in the critical path of regenerative medicine is the lack of suitable cells to restore function or repair damage. An "ideal" cell for cell therapy will possess the following attributes: (1) non-immunogenic, ideally patient derived; (2) controllable proliferation, allowing directed expansion; and (3) regulatable differentiation, with intrinsic restriction to the appropriate lineage. Primary cultures of somatic cells are not ideal, as they possess limited proliferative capacity and gradually lose their differentiated properties. Endogenous progenitor cells exist in various organs, including the lung ([@bib19], [@bib34], [@bib38], [@bib3], [@bib51], [@bib18]). However, these endogenous progenitor populations are often difficult to identify and isolate, and usually rapidly change *in vitro* ([@bib27]). In certain pathological conditions, they are limited in number and function ([@bib37], [@bib33]). Therefore, great efforts have been focused on exogenous cell sources. Despite significant progress in generating mature cell types using embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) ([@bib24], [@bib28], [@bib53], [@bib16], [@bib13]), some protocols remain limited by low yield and purity of the desired mature cell types. There is no standardized approach that is applicable to all cell types. Development of personalized therapies based on autologous pluripotent cells remains very expensive. Moreover, for many cell therapy applications the cells will need externally controllable proliferative capacity to maintain homeostasis or respond to injury.

The early steps of reprogramming have recently been the subject of intense investigations ([@bib9], [@bib17], [@bib25], [@bib42]). Two papers have documented additional alternative PSC states, specifically the F-class cells described by [@bib48], and separate populations expressing identified as either LIN28^high^ or NANOG^high^ by [@bib56]. In this work, we explore the earlier stages of iPSC reprogramming for potentially useful intermediate cell states. Reprogramming is a multistep process comprising initiation, maturation, and stabilization phases ([@bib39]) during continuous expression of exogenous reprogramming factors until the iPSC state is established ([@bib45]). There is a rapid induction of cell proliferation during the early phase of reprogramming ([@bib52]). Reprogrammed cells retain epigenetic "memory" in the process for significant numbers of doubling, with the cell of origin influencing the molecular epigenetic profile and functional differentiation potential of the iPSCs ([@bib21], [@bib32], [@bib43]). Herein, to create therapeutically valuable intermediate cellular products, we took advantage of this early proliferation and speculated that even greater residual epigenetic "memory" exists early in the reprogramming process.

For proof of principle we chose the lung, for which there has been recent progress in the identification of progenitor cells and their hierarchical relationships ([@bib34], [@bib38], [@bib27], [@bib8], [@bib3], [@bib49], [@bib51], [@bib18]), although there remains an unmet need to produce highly purified epithelial populations. For specificity we selected mature Club cells, which possess limited proliferative capacity *in vitro*. Interrupted reprogramming resulted in the generation of large numbers of epithelial progenitor-like cells that demonstrated controlled proliferation and restricted differentiation. This was achieved by optimized, controlled, transient induction of reprogramming factors, turning off their expression prior to reaching independent pluripotency ([Figure 1](#fig1){ref-type="fig"}A). We term these cells "induced progenitor-like" (iPL) cells.Figure 1CD31^−^CD45^−^EPCAM^high^ Epithelial Cells Are a Highly Purified Naphthalene-Sensitive Club Cell Population in which Regulation of Inductive Factors Results in Controlled Proliferation(A) Schematic graph depicting generation of iPL cells using interrupted reprogramming.(B) Representative flow-cytometry dot plots showing EPCAM^high^ and EPCAM^low^ cells in a parental population of CD31^−^CD45^−^ fresh isolated lung tissue digested cells.(C--E) Dot plots (C) showing that EPCAM^high^ cells are exclusive Club cells showing immunoactivity of CCSP. Relative expression of (D) Club cell and (E) other epithelial lineage-related genes to adult lung, comparing fold differences in gene expression in EPCAM^high^ (solid black bars) and EPCAM^low^ (open bars) cells.(F) Representative dot plots comparing EPCAM expression in CD45^−^CD31^−^ freshly isolated lung cells from non-treated and naphthalene-treated mice (n = 3).(G) Comparison of *Cyclin D1* expression in EPCAM^high^ cells and EPCAM^low^ cells.(H--M) Representative flow-cytometry dot plots showing CFSE-labeled cells at day 7 (untreated and Dox-treated). EPCAM^high^ cells (H) and EPCAM^low^ cells (I) maintained in feeder-separated semi-supportive culture for an additional 7 days with and without Dox treatment. Control untreated cells were cultured without Dox for the entire 2 weeks. Expression of (J) *mCol4F2A*, (K) *Cyclin D1*, (L) *Epcam*, and (M) Ccsp, comparing fold differences in gene expression of EPCAM^high^ freshly isolated (Day0), Dox-treated EPCAM^high^ at 1 week (1w^+Dox^), and induced cells cultured for an additional week in the presence (2w^+Dox^) and absence (1w^+Dox^+1w^−Dox^) of Dox.In (B), (C), (F), (H), and (I), data are representative of a minimum of three biological replicates. In (D), (E), (G), and (J)--(M), values are mean ± SD of three independent biological replicates. ^∗^p \< 0.05; ^∗∗^p \< 0.001; ^∗∗∗^p \< 0.0001.

Compared with the difficulty of developing directed differentiation protocols for each cell type required, isolation of highly purified populations of adult cells from most organs is already possible using flow-cytometric sorting and cell-culture techniques. These populations, if bestowed with controllable proliferative capacity and limited differentiation potential, would be extremely useful in a variety of regenerative medicine practices, including cell replacement therapy, biohybrid devices, disease modeling, and drug screening for human diseases.

Results {#sec2}
=======

Isolation and Identification of Terminally Differentiated Club Cells {#sec2.1}
--------------------------------------------------------------------

Club cells are secretory cells prominently found in the small bronchioles, identifiable by the presence of Club cell secretory protein (CCSP) ([@bib15]). The mature cells have very limited proliferative capacity. After injury, they are replaced from a pool of "variant" Club cells, which are resistant to toxins such as naphthalene. This population also then serves as progenitors for ciliated and mucous cell populations ([@bib34], [@bib35]). To demonstrate the value of the iPL cell approach, we chose to isolate this terminally differentiated population. Following a modified Club cell isolation protocol ([@bib2]), a CD45^neg^CD31^neg^EPCAM^pos^ profile defined two distinct epithelial populations, namely EPCAM^high^ and EPCAM^low^ cells ([Figure 1](#fig1){ref-type="fig"}B). The EPCAM^high^ population was exclusively Club cells expressing CCSP ([Figure 1](#fig1){ref-type="fig"}C) and Claudin10 ([@bib54]) ([Figure S1](#mmc1){ref-type="supplementary-material"}A), whereas the EPCAM^low^ population contained both Club cells and type II alveolar epithelial (AEC-II) cells ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}B). Club cell-related genes *Ccsp*, *Cyp2f2*, *Cldn10*, *Aox3*, and *Pon1* were detected within both populations with higher levels in the EPCAM^high^ population ([Figures 1](#fig1){ref-type="fig"}D and 1E). Naphthalene administration results in selective loss of mature Club cells ([@bib46]). To evaluate whether EPCAM^pos^ populations contained functionally different subtypes of Club cells, we compared EPCAM expression in cells isolated from naphthalene-treated and non-treated mice. EPCAM^high^ cells were nearly completely ablated with naphthalene treatment, confirming that they are naphthalene-sensitive, mature Club cells ([Figure 1](#fig1){ref-type="fig"}F).

Interrupted Reprogramming Allows OSKM-Dependent Proliferation of EPCAM^high^-Club Cells {#sec2.2}
---------------------------------------------------------------------------------------

EPCAM^pos^ cells were isolated from R26-rtTA/Col1a1:tetO-4F2A double transgenic mice ([@bib7]) enabling expression of Oct4, Sox2, Klf4, and c-Myc (OSKM) following treatment with doxycycline (Dox). To measure the proliferative response of EPCAM^pos^ cells to inductive factors, we used a specific 2D culture system allowing separation of seeded cells from a feeder population ([@bib20]) ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Control non-treated and Dox-treated EPCAM^high^ and EPCAM^low^ cells were labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE) dye at day 7 and maintained in culture for an additional week in the presence or absence of Dox. Non-treated EPCAM^high^ cells showed very limited proliferation consistent with lower expression of *Cyclin D1*, while Dox treatment resulted in significant proliferation of the majority of cells ([Figures 1](#fig1){ref-type="fig"}G and 1H). After treatment with Dox, EPCAM^high^ cells showed significant upregulation of the *4F2A* construct transgene and *Cyclin D1* ([Figures 1](#fig1){ref-type="fig"}J and 1K). Withdrawal of Dox stopped proliferation in the EPCAM^high^ group, while EPCAM^low^ cells continued to proliferate ([Figures 1](#fig1){ref-type="fig"}H and 1I). Note the spontaneous loss of EPCAM in the EPCAM^low^ population ([Figure 1](#fig1){ref-type="fig"}I). Importantly, *Epcam* and *Ccsp* expression re-emerged following withdrawal of Dox ([Figures 1](#fig1){ref-type="fig"}L and 1M). Thus, for these proof-of-principle studies we selected the EPCAM^high^ population, where, as non-proliferative mature Club cells, induced proliferation could be easily distinguished from endogenous proliferation.

Interrupted Reprogramming Results in Clonal Expansion of Quiescent Mature Club Cells without Traversing the Pluripotent State {#sec2.3}
-----------------------------------------------------------------------------------------------------------------------------

To better support epithelial cell growth, we cultured EPCAM^high^-Club cells in Matrigel-based 3D conditions and seeded them on inactivated mouse embryonic fibroblast (MEF) feeder cells prior to Dox treatment. No colonies were formed in the absence of Dox, confirming that native EPCAM^high^ cells lack clonogenic ability. Strikingly, Dox-treated cells exhibited clonogenic growth ([Figure 2](#fig2){ref-type="fig"}A) showing epithelial colonies with hollow lumina ([Figures 2](#fig2){ref-type="fig"}B and 2C). Time-course analysis indicated that lumen formation occurred as early as day 4 ([Figure S2](#mmc1){ref-type="supplementary-material"}A). This lumen formation occurs at least in part via apoptosis ([@bib14]), marked by caspase-3 expression ([Figure S2](#mmc1){ref-type="supplementary-material"}B), and apical-basal polarization ([@bib26]), as shown by basolateral distribution of EPCAM ([Figure 2](#fig2){ref-type="fig"}C) and apical expression of ZO-1 ([Figure S2](#mmc1){ref-type="supplementary-material"}C). Dox induction for 3 weeks (3w^+Dox^) resulted in suppression of CCSP without activation of the pluripotency marker, NANOG ([Figures 2](#fig2){ref-type="fig"}D and [3](#fig3){ref-type="fig"}E). An additional 2 weeks of Dox treatment (5w^+Dox^) resulted in 22.9% ± 8.3% of colonies becoming NANOG positive ([Figure 2](#fig2){ref-type="fig"}E). *In vivo*, 3w^+Dox^ cells injected into NOD/SCID mice failed to form tumors or teratomas over a 6-month observation period. In contrast, mice developed teratomas 2--3 weeks after injection with either R1 ESCs ([@bib30]) or 5w^+Dox^ cells ([Figures 2](#fig2){ref-type="fig"}G and [S2](#mmc1){ref-type="supplementary-material"}D). Thus, we selected a 3-week induction period during which we achieved the greatest level of expansion without activation of Nanog expression, and hereafter term the 3w^+Dox^ cells Club-iPL cells. During this 3-week period of expansion, cells were serially passaged in the presence of Dox, retained colony-forming potential ([Figure 2](#fig2){ref-type="fig"}H, right y axis), and showed an exponential increase in total cell number (∼30-fold expansion) ([Figure 2](#fig2){ref-type="fig"}H, left y axis). Microarray analysis of genome-wide transcriptional changes showed that Club-iPL cells have minimal expression of ESC-related genes (e.g., *Nanog*, *Utf1*, *Dapp4*) and maintained significant overlapping expression of Club cell-related genes ([Figure 2](#fig2){ref-type="fig"}I).Figure 2Carefully Defined Length of Interrupted Reprogramming Results in Efficient Clonal Expansion of Quiescent Mature Club Cells without Traversing the Pluripotent State *In Vitro*(A) Light microscopy bright-field images showing the generation of hollow-luminal colonies in the presence of doxycycline in Matrigel-based clonogenic 3D conditions.(B) H&E staining of sectioned EPCAM^high^ cell-derived colonies under Dox treatment showing hollow-luminal morphology.(C) Confocal microscopy images of induced colonies derived from GFP-Club cells stained with nuclear stain DAPI (blue), GFP (green), and EPCAM (red).(D--G) Confocal microscopy images depicting (D) 3-week-induced colonies (3w^+Dox^) stained with nuclear stain DAPI (blue), OCT4 (green), and NANOG (red). Immunostaining of 5-week-induced colonies (5w^+Dox^) (E) showing NANOG immunoactivity as that seen in R1 ESCs (F). In an *In vivo* teratoma assay (G), R1 ESCs (positive control), 3w^+Dox^ Club-iPL cells, and 5w^+Dox^ cells were transplanted into NOD/SCID mice (n = 2 mice for each group).(H) Bulk serial passage of induced colonies during the 3 weeks of induction. Left y axis represents the fold change in total cell number relative to day-0 seeded cells (10,000 cells/well). Right y axis represents the total number of colony-forming units generated. Values are mean ± SD of three independent biological replicates.(I) Microarray analysis scatterplot showing comparison of iPSCs (generated from EPCAM^high^-Club cells) with day-0 and Club-iPL cells (left panel); pie charts depicting number of genes overlap in clusters A and B (right panel).Scale bars, 100 μm (A--C) and 10 μm (D--F).Figure 3Interrupted Reprogramming Allows EPCAM^high^-Club Cell-Derived iPL Cell Colonies to Return to Their Original Epithelial Phenotype upon Factor Withdrawal(A--H) Expression of (A) the transgene construct *mCol4F2A*, (B) *Cyclin D1*, (C) *Ccsp*, and (D) *Nanog*, as measured by qRT-PCR comparing fold differences in gene expression in freshly isolated cells (Day0), 3w^+Dox^ (Club-iPL cells), Club-iPL cells with subsequent 2-week culture in Dox-free medium (3w^+Dox^+2w^−Dox^), and 5-week-induced cells (5w^+Dox^). Confocal microscopy images of (E) 3w^+Dox^ (Club-iPL cells) colonies, (F) colonies obtained from 3w^+Dox^ (Club-iPL cells) maintained in culture for 2 weeks in the absence of Dox (3w^+Dox^+2w^−Dox^), (G) NANOG-negative colonies, and (H) NANOG--positive colonies obtained from 4-week-induced cells (4w^+Dox^) cultured without Dox for 1 subsequent week (4w^+Dox^+1w^−Dox^), showing cells stained with nuclear stain DAPI (blue), OCT4/NANOG (gray), Pan-CK (red), and CCSP (green).(I) Representative flow-cytometry dot plots showing expression of EPCAM and CCSP in 3w^+Dox^ Club-iPL cells, and iPL cells cultured without Dox for 2 subsequent weeks (3w^+Dox^+2w^−Dox^).(J) Unbiased clustering analysis of all genes expressing ≥3-fold change (5,966/24,779).(K) Self-organizing map analysis of genes that exhibited a \>3-fold gene expression difference between cell samples.For (A)--(D), values are mean ± SD of three independent biological replicates. For (I), data are representative of a minimum of three independent biological replicates. ^∗^p \< 0.05; ^∗∗^p \< 0.001; ^∗∗∗^p \< 0.0001. Scale bars, 100 μm (E--H).

Interrupted Reprogramming Allows Club-iPL Cells to Return to Their Original Epithelial Phenotype upon Withdrawal of Factors {#sec2.4}
---------------------------------------------------------------------------------------------------------------------------

We assessed the ability of Club-iPL cells to return to their original epithelial phenotype following withdrawal of Dox. Two weeks after withdrawal of Dox (3w^+Dox^+2w^−Dox^), cells turned off transgene *4F2A* expression and downregulated *Cyclin D1* ([Figures 3](#fig3){ref-type="fig"}A and 3B). Expression of the four individual factors was also significantly downregulated ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Some epithelial genes, such as *Epcam* and *E-cadherin*, were well maintained both with treatment and upon withdrawal of Dox ([Figure S3](#mmc1){ref-type="supplementary-material"}B). CCSP, which was markedly suppressed after 3 weeks of Dox treatment, was expressed at robust levels upon withdrawal of Dox ([Figures 3](#fig3){ref-type="fig"}C, 3E, 3F, and 3I). Importantly, NANOG expression was not observed in either Club-iPL cells or 3w^+Dox^+2w^−Dox^ cells ([Figures 3](#fig3){ref-type="fig"}D and 3F) whereas in 4w^+Dox^+1w^−Dox^ cells, a few NANOG^+^ colonies were observed ([Figures 3](#fig3){ref-type="fig"}G and 3H). Unbiased clustering analysis of the genes with a change ≥3-fold (5,966/24,779 genes) demonstrated that the induced cell groups clustered with the day-0 group ([Figure 3](#fig3){ref-type="fig"}J). Further analysis showed that the expression of large numbers of genes temporally changed during Dox-driven expansion of Club cells but returned upon withdrawal of the factors. These gene clusters were enriched for epithelial genes by gene ontology analysis ([Figure 3](#fig3){ref-type="fig"}K, top). Other genes demonstrating progressive changes were enriched for metabolism and cell adhesion functions ([Figure 3](#fig3){ref-type="fig"}K, bottom), suggestive merely of adaptation to the *in vitro* environment. [Figure S3](#mmc1){ref-type="supplementary-material"}C shows a heatmap of the genes shown in [Figure 2](#fig2){ref-type="fig"}I across all four groups.

Interrupted Reprogramming Allows Preservation of Lineage Commitment {#sec2.5}
-------------------------------------------------------------------

To ensure that Club-iPL cells have restricted differentiation, we accessed lineage preference via *in vitro* differentiation assays. Immunostaining of bulk colonies for Pan-CK (endodermal epithelial cells), α-actinin (mesodermal cardiomyocytes), and β-tubulin III (ectodermal neuron cells) demonstrated that Club-iPL cells only developed along an epithelial lineage ([Figure 4](#fig4){ref-type="fig"}A). In contrast, cells treated with Dox for 8 weeks (8w^+Dox^), in addition to showing Pan-CK expression ([Figure 4](#fig4){ref-type="fig"}B), were able to generate α-actinin^+^ ([Figure 4](#fig4){ref-type="fig"}C) and β-tubulin III^+^ cells ([Figure 4](#fig4){ref-type="fig"}E). NANOG^+^ undifferentiated cells were also observed ([Figure 4](#fig4){ref-type="fig"}D). Moreover, Club-iPL cells exhibited a higher tendency for generation of ciliated cells (β-tubulin IV^+^: 66.7% ± 7.6% of cells) compared with 8w^+Dox^ cells (β-tubulin IV^+^: 25.2% ± 5.1% of cells) ([Figure 4](#fig4){ref-type="fig"}F). The existence of mixed populations of differentiated cells and undifferentiated cells from the long-term-induced cell group suggests that prolonged induction results in greater divergence from the original lineage and enhanced pluripotency, if not full creation of traditional iPSCs. Lineage commitment at the single-cell level was assessed by culturing independent colonies in three different media reported to direct differentiation to either neuronal, cardiomyocyte, or epithelial lineages (12 colonies/condition) ([Figure S4](#mmc1){ref-type="supplementary-material"}A). Club-iPL colonies remain committed to an epithelial fate generating Pan-CK^+^ cells but not cardiac troponin T (cTnT)-expressing or β-tubulin III-expressing cells ([Figures 4](#fig4){ref-type="fig"}G--4I and [S4](#mmc1){ref-type="supplementary-material"}B).Figure 4Interrupted Reprogramming Allows Preservation of Lineage Preference and Commitment(A) Confocal microscopy images of bulk-passaged Club-iPL (3w^+Dox^) cells, following *in vitro* culture under pluripotency assay conditions. Images show staining for nuclear stain DAPI (blue), Pan-CK (green), α-actinin (red), and tubulin III (gray).(B--D) Cells induced for 8 weeks (8w^+Dox^), under *in vitro* pluripotency assay conditions with (B) Pan-CK (green), (C) α-actinin (red), and (D) NANOG (red), respectively.(E and F) Confocal microscopy images of Club-iPL (3w^+Dox^) cells and 8-week-induced (8w^+Dox^) cells under (E) neuron cell differentiation assay conditions showing tubulin III (green) staining and (F) under ALI ciliated cell differentiation conditions showing β-tubulin IV (green) staining.(G--I) Confocal microscopy images of cells dissociated from single Club-iPL colonies cultured on 10% Matrigel-coated plate under conditions reported for (G) epithelial cells, (H) cardiomyocytes, and (I) neurons. Images show staining for nuclear stain DAPI (blue), Pan-CK (red), tubulin III (green), and cTnT (gray in G, green in H) (n = 12 colonies/each condition).Scale bars, 10 μm (C and E) and 100 μm (A, B, D, and F--I).

Club-iPL Cells Function as Multipotent Bronchiolar Progenitor-like Cells {#sec2.6}
------------------------------------------------------------------------

We evaluated the differentiation potential of Club-iPL cells using a two-step protocol ([Figure 5](#fig5){ref-type="fig"}A) whereby Club-iPL cells were cultured without Dox for 2 weeks (first step) followed by air-liquid interface (ALI) conditions for 2--3 weeks (second step). The first step of differentiation resulted in upregulation of CCSP ([Figures 5](#fig5){ref-type="fig"}B and 5D). Under second-step ALI conditions, iPL cells spontaneously differentiated to MUC5AC-expressing mucin-producing goblet cells ([Figure 5](#fig5){ref-type="fig"}E) and β-tubulin IV-expressing ciliated cells ([Figure 5](#fig5){ref-type="fig"}F), coinciding with downregulation of *Ccsp* ([Figure 5](#fig5){ref-type="fig"}B) and upregulation of *Foxj1* mRNA levels ([Figure 5](#fig5){ref-type="fig"}C). Thus, Club-iPL cells can function as multipotent bronchiolar progenitor-like cells, giving rise to Club, goblet, and ciliated cells ([Figure 5](#fig5){ref-type="fig"}G).Figure 5Club-iPL Cells Function as Multipotent Bronchiolar Progenitor-like Cells(A--C) Schematic graph representing a two-step differentiation protocol (A). Comparison of fold differences in *Ccsp* (B) and *Foxj*1(C) gene expression in adult lung, freshly isolated day-0 cells, 3w^+Dox^+2w^−Dox^ cells (pre-ALI), and cells subsequently cultured in ALI conditions for 2--3 weeks (ALI) by qRT-PCR.(D--F) Confocal microscopy images showing (D) immunostaining of iPL cells after the first step in the differentiation protocol, with nuclear stain DAPI (blue), Pan-CK (red), and CCSP (green); immunostaining of cells after the second step of differentiation protocol with (E) nuclear stain DAPI (blue), E-cadherin (red), and MUC5AC (green) (arrowheads, MUC5AC^high^ cells); and with (F) nuclear stain DAPI (blue) and β-tubulin IV (green).(G) Schematic graph depicting the differentiation capacity of 3w^+Dox^ (Club-iPL) cells.For (B) and (C), values are mean ± SD of three independent biological replicates. ^∗^p \< 0.05; ^∗∗^p \< 0.001; ^∗∗∗^p \< 0.0001.Scale bars, 10 μm (D--F).

Club-iPL Cells Are Able to Generate Functional CFTR-Expressing Ciliated Epithelium {#sec2.7}
----------------------------------------------------------------------------------

Cystic fibrosis transmembrane conductance regulator (CFTR), mainly expressed in ciliated epithelium in the lung, encodes a cyclic AMP (cAMP)-regulated chloride channel that plays a critical role in regulating chloride and water transport. Ciliated epithelium derived from iPL cells expressed functional CFTR protein. We observed that 61.9% ± 6.1% of E-cadherin^+^ cells expressed CFTR, consistent with the formation of functional ciliated epithelium with tight junctions ([Figure 6](#fig6){ref-type="fig"}A). We confirmed the apical membrane localization of CFTR while E-cadherin staining was visualized at the lateral membranes ([Figure 6](#fig6){ref-type="fig"}B). ALI conditioning resulted in CFTR-expressing cells ([Figure 6](#fig6){ref-type="fig"}C). Gene expression analysis of ALI-conditioned cells compared with pre-ALI cells showed a reduction of *Ccsp* expression ([Figure 5](#fig5){ref-type="fig"}B) and marked upregulation of *Cftr* ([Figure 6](#fig6){ref-type="fig"}D), suggesting the appropriate differentiation of expanded Club cells to CFTR-expressing ciliated cells. An iodide efflux assay measuring cAMP agonist stimulation of the CFTR channel suggests that CFTR seen in Club-iPL-derived ciliated epithelium was functional and appropriately regulated ([Figure 6](#fig6){ref-type="fig"}E).Figure 6Club-iPL Cells Are Able to Generate Functional CFTR-Expressing Ciliated Epithelium *In Vitro*, which Are Useful as a Component of Cell Replacement Therapy for Cystic Fibrosis *In Vivo*(A) Confocal microscopy images showing immunostaining of ALI-conditioned iPL cells, with nuclear stain DAPI (blue), E-cadherin (red), and CFTR (green).(B) Reconstruction of x-z projections of horizontal sections showing nuclear stain DAPI (blue), the apical membrane staining of CFTR (green), and the lateral membrane staining of E-cadherin (red).(C) Flow-cytometry analysis of CFTR expression in freshly isolated (Day0) cells and ALI-conditioned cells.(D) Comparison of fold differences in *Cftr* gene expression in adult lung, freshly isolated (Day0) cells, pre-ALI cells, and ALI-conditioned cells.(E) Iodide efflux assay showing CFTR activity in ALI-iPL cells (blue line) induced by cAMP agonist.(F--K) Confocal microscopy images of (F) native B57/L6 airway control, (G) native CFTR-KO airway epithelium, and injured airway epithelium of CFTR-KO mice at (H) 1 week and (I) 3 weeks post naphthalene treatment showing nuclear stain DAPI (blue) and CFTR (gray). Confocal microscopy images of iPL cell-treated injured airway sections 1 week (J) and 3 weeks (K) post cell delivery, showing nuclear stain DAPI (blue), GFP (green), ZO-1/E-cadherin (red), and CFTR (gray).(L) Western blot showing the presence of CFTR protein band appearing at approximately 170 kDa, representative of the complex glycosylated functional form of CFTR in homogenized lung tissue from iPL cell-treated CFTR-knockout injured mice.(M and N) Expression levels of (M) *Ccsp* and (N) *Cftr* in recipient lungs, as measured by qRT-PCR comparing fold differences in expression in wild-type lungs.For (C), data are representative of a minimum of three biological replicates. For (D), (E), (M), and (N), values are mean ± SD of three independent biological replicates. ^∗^p \< 0.05; ^∗∗^p \< 0.001; ^∗∗∗^p \< 0.0001. Scale bars, 10 μm (A, B, and F--K).

Club-iPL Cells Are Useful in Cell Replacement Therapy for Cystic Fibrosis *In Vivo* {#sec2.8}
-----------------------------------------------------------------------------------

The engraftment of Club-iPL cells into CFTR-deficient epithelium was assessed *in vivo*. For tracking purposes, ROSA26-rtTA/Col1a1: tetO-4F2A double transgenic mice were bred to actin GFP mice and GFP^+^ Club-iPL cells were delivered to CFTR-knockout mice transtracheally following our previously reported conditioning regimen ([@bib11], [@bib12]) to augment retention of delivered cells. The engraftment and differentiation capacity of Club-iPL cells in recipient lungs were assessed via staining for ZO-1 or E-cadherin, anti-GFP, and epithelial-type specific markers at 7 and 21 days after cell delivery. CFTR expression in airways of wild-type mice was used as a positive control ([Figure 6](#fig6){ref-type="fig"}F) while non-treated and naphthalene-treated CFTR-knockout mice served as negative controls ([Figures 6](#fig6){ref-type="fig"}G--6I). Injected GFP cells expressed ZO-1 and E-cadherin, suggestive of their incorporation in recipient epithelium. CFTR-expressing GFP cells were found at days 7 and 21 ([Figures 6](#fig6){ref-type="fig"}J and 6K) after iPL cell treatment. Western blotting ([Figure 6](#fig6){ref-type="fig"}L) confirmed expression of CFTR protein. A faint band of immature hypoglycosylated CFTR was seen in the untreated CFTR-knockout controls, as expected (in this transgenic animal where the lung is known to have low-level expression of human CFTR) ([@bib55]). They also increased expression of *Ccsp* and partially restored expression of *Cftr* in CFTR-deficient lungs ([Figures 6](#fig6){ref-type="fig"}M and 6N). Consistent with *in vitro* results, CCSP and α-tubulin staining confirmed the differentiation of engrafted Club-iPL cells to Club cells and ciliated cells *in vivo* ([Figures S5](#mmc1){ref-type="supplementary-material"}A--S5E). No SPC^+^ or AQP5^+^ GFP^+^ cells were found, *in vitro* or *in vivo* (data not shown), consistent with restricted commitment to the bronchiolar lineage. To quantify retention, we measured genomic DNA for *GFP* using a standard curve. Donor iPL cells were retained in recipient lungs ([Figure S5](#mmc1){ref-type="supplementary-material"}F) with no significant difference between 7 days (27.8% ± 12.2% of the initial injected cell number) and 21 days (25.8% ± 12.1%) after cell delivery. We also examined the long-term tumorigenicity of iPL cell lines *in vivo* (n = 3). Whole body micro-computed tomography scans taken at 9 months after iPL cell delivery showed no tumors ([Figure S5](#mmc1){ref-type="supplementary-material"}G).

Discussion {#sec3}
==========

A carefully defined period of interrupted reprogramming enabled quiescent mature Club cells to proliferate and start the reprogramming process, but not pass the point of no-return ([@bib29]), thereby generating large numbers of iPL cells. Upon withdrawal of the inductive factors, iPL cells give rise to CCSP^+^ Club cells, mucin^+^ goblet cells, and functional CFTR-expressing ciliated epithelium *in vitro*. They show *in vivo* utility by repopulating CFTR-knockout epithelium after a recipient conditioning regimen. Our results suggest that interrupted reprogramming is not only able to achieve controlled expansion of the selected cell type, but results in the "dedifferentiation" of the cells to a progenitor-like state while preserving the differentiation potential of the parental population to generate a limited range of functional progeny.

Recent advances in the understanding of the mechanisms involved in iPSC reprogramming have demonstrated that "epigenetic memory" found both in human and mouse iPSCs renders them permissive to preferential differentiation to the original lineage ([@bib21], [@bib4], [@bib43], [@bib10]). In our study, we harnessed this "residual epigenetic memory" of the starting cells and generated large numbers of relatively pure progenitor-like populations with intrinsic restriction to the appropriate lineage.

Despite recent progress in delineating a number of lung progenitor populations and some of their associated markers ([@bib8], [@bib18], [@bib19], [@bib27], [@bib34], [@bib38], [@bib49], [@bib51]), we are still limited in our grasp of the number and characteristics of the lung stem cell hierarchy. After careful comparison using available specific marker expression and microarray data for known lung progenitor populations ([@bib38], [@bib51]), P63-expressing Club-iPL cells do not resemble any *currently identified* progenitors ([Figures S6](#mmc1){ref-type="supplementary-material"}A--S6H). It remains a possibility that they represent a yet unidentified progenitor cell population. Alternatively, transient expression of OSKM in mature lung epithelial cells could result in the generation of a progenitor population not existing in the developing or mature lung---that is, bearing no clear relation to cells in the natural state but nonetheless capable of controlled expansion and differentiation to a limited and appropriate range of progeny. Recent reports highlight the existence of multiple unique cell states en route to pluripotency ([@bib17], [@bib48], [@bib56], [@bib50]). Whether or not iPL cells recapitulate a specific developmental stage, enhanced proliferation, and restricted differentiation makes them useful, especially given that this technology can theoretically be applied to almost any cell type that can be isolated and purified.

Superior self-renewal and differentiation capacity of ESCs and iPSCs make both very useful for regenerative medicine, but protocols to generate large numbers of pure, fully differentiated cells are still imperfect. Problems include low differentiation efficiency, heterogeneous final products ([@bib31], [@bib41]), and contamination by potentially tumorigenic undifferentiated cells ([@bib5], [@bib47]). A variety of approaches may overcome these problems, but producing each unique cell that may be desirable will require the development of hundreds of unique protocols. Direct reprogramming through ectopic expression of combinations of specific transcription factors ([@bib6], [@bib40]) and/or microRNA ([@bib1], [@bib22]), resulting in direct conversion from one cell type to another, has also been extensively studied. Direct conversion does not require a pluripotent intermediate state and thus may raise fewer safety concerns. Our interrupted reprogramming strategy similarly avoids pluripotency but may be easier to apply to a broad range of cell types, only requiring that they can be isolated in relative purity.

Recent studies showed *in vitro* differentiation of iPSCs and ESCs to lung epithelium, but were not able to generate large numbers of either Club cells or ciliated cells. Importantly, none of these groups evaluated the *in vivo* contribution of resultant CFTR-expressing cells in an animal model. On the contrary, our iPL cells hold great promise for treating respiratory diseases. Our proof-of-concept *in vivo* studies showed successful retention and incorporation in CFTR-deficient epithelium, with injected iPL cells being able to give rise to both Club cells and ciliated cells.

The significance of this concept results in a number of key issues that need to be addressed. Firstly, our current report suggested that iPL cells are not yet pluripotent. However, our proof-of-principle study was performed using a Dox-inducible polycistronic OSKM system that is known to have a low efficiency for generating bona fide iPSCs, and the absolute safety of this approach requires further evaluation in different OSKM expression systems. Secondly, although we have selected a highly purified population of cells as the starting material, interrupted reprogramming still produces clones that are variable in size, suggesting some degree of heterogeneity in the system. While proliferation during iPL induction seems relatively uniform ([Figure 1](#fig1){ref-type="fig"}H, middle panel) and the observed return to phenotype upon Dox withdrawal ([Figure 2](#fig2){ref-type="fig"}I) is also homogeneous, potential pluripotency (as suggested by NANOG expression) is more heterogeneous, varying between colonies and among cells within an individual colony after a prolonged induction period (\>5 weeks). This will need further exploration but is not surprising, as evidence suggests higher levels of heterogeneity in the early phases of iPSC induction ([@bib25], [@bib50], [@bib56]). There is also some heterogeneity in the differentiation capacity of the Club cells after return from the iPL state, although this can be attributed to the normal biology of Club cells ([@bib34], [@bib36]). We also explored the potential of cyclical interrupted reprogramming for even greater expansion of iPL cells *in vitro* ([Figures S6](#mmc1){ref-type="supplementary-material"}I--S6K) and in repopulating injured airway epithelium *in vivo* ([Figures S6](#mmc1){ref-type="supplementary-material"}L--S6P). While significant increases in cell numbers were seen, the number of cycles resulting in maximal expansion of cells without loss of iPL function remains to be determined. Further refinement is needed to widen the relatively narrow time window during which iPL cell induction and expansion is maximized but before potential factor-independent pluripotency is possible. This may require optimization of exogenous growth factors and/or changes to culture conditions. In addition, the precise requirement for each individual transcription factor remains unknown. Future studies need to be performed to clarify the mechanism underlying the iPL phenomenon and examine whether all factors are necessary. Singovski and colleagues evaluated the effect of transient activation of OSKM, OSK, and M alone ([@bib44]). While *c-Myc* was important for driving proliferation, only the full four factors resulted in acquisition of a robust "cancer stem cell" phenotype, including increase in colony-forming efficiency. This suggests that the combination of all four factors has downstream effects beyond simply *Myc*-driven proliferation. Whether this observation is analogous to our non-malignant "progenitor-like" population remains to be studied. Finally, regarding therapeutic use, the current data were obtained from Col1a1-4F2A mice and it remains to be shown that this technique can be efficiently applied in human cells. In preliminary studies, we isolated normal human lung epithelial cells containing Club cells from excess tissue remaining from lung transplant donors. Cells were transfected with a polycistronic lentiviral vectors driving Dox-regulatable OSKM. Although the induction conditions require further optimization, Dox-induction resulted in increased cell numbers compared with non-treated native epithelial cells ([Figure S6](#mmc1){ref-type="supplementary-material"}Q). Importantly, consistent with our observation in the mouse system, Dox-treated cells lost their somatic *CCSP* gene expression but regained it following Dox-withdrawal, suggestive of the ability to return to their original phenotype ([Figure S6](#mmc1){ref-type="supplementary-material"}R). The iPL cell induction process will need to be optimized to obtain maximum expansion and scale-up of cells, but should theoretically benefit from the advances driving iPSC research toward non-integrative, non-viral methods of reprogramming. Theoretically, our iPL concept is broadly applicable and could be extended to other somatic cell types, giving rise to numerous progenitor cell populations. Although future investigations will be needed, these proof-of-concept *in vivo* studies showed that iPL cells hold great promise for treating respiratory diseases by true engraftment as "induced" progenitors.

Experimental Procedures {#sec4}
=======================

Naphthalene Administration and Cell Delivery {#sec4.1}
--------------------------------------------

Naphthalene (\>99% pure; Sigma-Aldrich, St Louis, MO) was dissolved in Mazola corn oil and injected as described previously ([@bib46]). Busulfan (Otsuka America Pharmaceutical, Rockville, MD) was given by intraperitoneal injection 1 day after naphthalene treatment at a dose of 20--50 mg/kg, and donor cells were transplanted the following day (10^6^ cells in 50 μL of PBS) transtracheally using sterile gel-loading tips. The mice receiving donor cells were rotated to ensure equal dispersion of cell suspension to both lungs.

Cell Culture {#sec4.2}
------------

### Matrigel-Based iPL Cell Induction {#sec4.2.1}

Feeders (MEF) were seeded on 0.1% gelatin coated 24-well transwell filter inserts (Corning) 1 day prior to the addition of epithelial cells. Sorted epithelial cells resuspended in 100 μL of Matrigel (BD Biosciences) prediluted 1:1 (v/v) with epithelial-specific medium were added to MEF-coated 24-well transwell filter inserts in a 24-well tissue culture plate containing 500 μL of epithelial medium for 3--5 days, then replaced with ESC medium containing 1.5 μg/mL doxycycline (Sigma). Medium was replenished three times per week. For bulk passaging, whole cultures were dissociated in collagenase (1 mg/mL; Sigma)/dispase (3 mg/mL; BD Biosciences) in PBS to generate a single-cell suspension. For clonal passaging, single colonies were picked and dissociated.

*In Vitro* Differentiation Assays {#sec4.3}
---------------------------------

To examine the *in vitro* potential of these cells to differentiate along certain lineages, we performed a variety of differentiation assays. iPL cells induced for 3 weeks were compared with a positive control group consisting of cells exposed to reprogramming factors for 8 weeks.

### Air-Liquid Interface Differentiation Assay {#sec4.3.1}

Prior to the ALI assay, induced cells were cultured and recovered in ESC medium for 2 weeks. For ALI culture, the ESC medium from the upper chamber was removed to expose cells to the air while medium in the lower chamber was replaced with ALI-specific medium (Lonza). Medium was replenished twice per week and cells were maintained under ALI conditions for 2--3 weeks.

### *In Vitro* Pluripotency Assay {#sec4.3.2}

An *in vitro* pluripotency assay to assess the potential of these cells to develop into a variety of cell lineages was performed ([@bib23]). In brief, induced cells were dissociated and digested to single-cell suspension and then resuspended in 50% (Matrigel) and 20% fetal bovine serum containing medium supplemented with: activin-A (20 ng/mL), transforming growth factor β1 (2 ng/mL), 10 g/mL insulin, 5 g/mL transferrin, and 300 ng/mL retinoic acid for 2--3 weeks. Lineage differentiation was assessed by immunostaining of pan-cytokeratin, α-actinin, and β-tubulin III.

### Neuron Differentiation Assay {#sec4.3.3}

To determine the lineage commitment of induced cells, we performed a defined neuron differentiation assay (Millipore) with slight modifications. In brief, 3-week- and \>8-week-induced cells from Matrigel cultures were digested to single-cell suspension and differentiated under neuron-specific conditions for 2--3 weeks following the manufacturer\'s protocol. Generation of neurons was accessed by immunostaining of β-tubulin III.

Microarray and Data Analysis {#sec4.4}
----------------------------

Total RNA was extracted using an RNeasy kit (Qiagen, Canada). Equal amounts of RNA from three separate samples in each group were used for microarray. Microarray expression profiling using Mouse Gene 2.0 ST chips was performed by The Center for Applied Genomics (The Hospital for Sick Children, Toronto, Canada). Gene ontology term analysis was performed by the DAVID Bioinformatics tool. Self-organizing map analysis of gene expression was performed with the use of the analysis tool MultiExperiment Viewer.
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